Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FZ0U7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,665
Award facts
- Contract value 100% obligated
- $24,665.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 15, 2026, for GEMTESA 75 mg tablets (90-count units) valued at $24,665.23 with a firm fixed-price structure. The contract completion date is scheduled for January 16, 2026, and represents a child award under the parent entity Cencora, Inc. (doing business as AmerisourceBergen). This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to compete on a full and open basis for federal pharmaceutical procurement requirements.
This award is issued under AmerisourceBergen's significant Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of prescription medications, generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen supplies essential pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating the company's established role as a critical vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FZ0U7?
SPE2DR26FZ0U7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FZ0U7 worth?
The government has obligated $24,665 on SPE2DR26FZ0U7.
Is contract SPE2DR26FZ0U7 an order under another contract?
Yes. SPE2DR26FZ0U7 is a delivery order under SPE2DR25D2018, an indefinite delivery contract.
Was contract SPE2DR26FZ0U7 competed?
The extent of competition for SPE2DR26FZ0U7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award